Terms and Synonyms Searched:
| Terms | Search Results* | Entire Database** |
|---|---|---|
| Synonyms | ||
| ALEMTUZUMAB | 40 studies | 398 studies |
| campath | 23 studies | 254 studies |
| anti-CD52 monoclonal antibody | 9 studies | 21 studies |
| MoAb CD52 | 6 studies | 9 studies |
| Monoclonal Antibody CD52 | 6 studies | 9 studies |
| Anti-CD52 Antibody | 1 studies | 6 studies |
| MabCampath | 1 studies | 31 studies |
| LDP-03 | -- | 3 studies |
| Lemtrada | -- | 32 studies |
| Monoclonal | 40 studies | 6,949 studies |
| B-Cell | 40 studies | 5,644 studies |
| B lymphocyte | 1 studies | 351 studies |
| Bursa Dependent Lymphocytes | -- | 1 studies |
| Lymphocytes B | -- | 14 studies |
| Campath-1H | 40 studies | 398 studies |
| ALEMTUZUMAB | 39 studies | 369 studies |
| campath | 23 studies | 254 studies |
| anti-CD52 monoclonal antibody | 9 studies | 21 studies |
| MoAb CD52 | 6 studies | 9 studies |
| Monoclonal Antibody CD52 | 6 studies | 9 studies |
| Anti-CD52 Antibody | 1 studies | 6 studies |
| MabCampath | 1 studies | 31 studies |
| LDP-03 | -- | 3 studies |
| Lemtrada | -- | 32 studies |
| Phase II | 40 studies | 75,444 studies |
| phase 2 | 38 studies | 71,934 studies |
| 2 phases | -- | 328 studies |
| phase two | -- | 126 studies |
| second phase | -- | 769 studies |
| Phase | 40 studies | 199,902 studies |
| Stage | 24 studies | 31,337 studies |
| Phased | -- | 186 studies |
| -- | No studies found |
| * | Number of studies in the search results containing the term or synonym |
| ** | Number of studies in the entire database containing the term or synonym |